Mangoceuticals Inc (MGRX) Gross Profit Margin starting from the second quarter 2026 to second quarter 2025, Profitability Trends and Ranking, Fundamental Ratios - CSIMarket
CSIMarket
 


Mangoceuticals Inc   (NASDAQ: MGRX)
    Sector  Healthcare    Industry Healthcare Facilities
   Industry Healthcare Facilities
   Sector  Healthcare


Mangoceuticals Inc 's Gross Profit Margin by quarter

Trends, Rankings, Statistics



MGRX Gross Profit Margin (Jun 30 2026)
Q2
(Mar 31 2026)
Q1
(Dec 31 2025)
Q4
(Sep 30 2025)
Q3
(Jun 30 2025)
Q2
Y / Y Revenue Change -59.1 %
Seq. Revenue Change 1.32 %
Revenue In Millions $0.07
Gross Profit Margin 84.82 %
Gross Profit Margin Total Ranking # 1977
Gross Profit In Millions $0.06
Y / Y Gross Profit Change -35.16 %
Seq. Gross Profit Change 101.1 %


Commenting Second Quarter 2026 Gross Profit Margin
Mangoceuticals Inc Gross Profit grew by 101.1 % in Q2 sequentially to 0 millions, while Revenue increased by 1.32 %, this led to improvement in the company's Gross Profit Margin to 84.82 % a new company high.


Observing second quarter 2026 results within Healthcare Facilities industry 17 other companies have achieved higher Gross Profit Margin. While Gross Profit Margin overall ranking has deteriorated relative to the three months before, from 1821 to 1977.
Learn about Gross Margin
MGRX's Gross Profit Margin second quarter 2026 Company Ranking
Within: No.
Healthcare Facilities Industry # 18
Healthcare Sector # 343
Overall # 1960

Gross Profit Margin Statistics
High Average Low
84.82 % 59.58 % 42.73 %
(Jun 30 2026)   (Mar 31 2026)




Other Gross Profit Margin Profitability Ratios
MGRX's Cumulative Gross Profit Margin
Healthcare Facilities Industry Gross Profit Margin Trends and Statistics
Healthcare Sector Gross Profit Margin Statistics
Gross Profit Margin Profitability Trends for overall market
MGRX's Gross Profit Margin Profitability versus Healthcare Facilities Industry, Healthcare Sector and total Market
Highest Ranking Gross Profit Margin
Lowest Ranking Gross Profit Margin
Gross Profit Margin Profit Margin for MGRX's Competitors
Gross Profit Margin Profit Margin for Mangoceuticals Inc 's Suppliers
Gross Profit Margin Profit Margin for MGRX's Customers

You may also want to know
MGRX's Annual Growth Rates MGRX's Profitability Ratios MGRX's Asset Turnover Ratio MGRX's Dividend Growth
MGRX's Roe MGRX's Valuation Ratios MGRX's Financial Strength Ratios MGRX's Gross Profit Growth
MGRX's Roa MGRX's Inventory Turnover Ratio MGRX's Growth Rates MGRX's Dividend Comparisons


Companies with similar Gross Profit Margin in the quarter ending Jun 30 2026, within Healthcare Facilities Industry Gross Profit MarginJun 30 2026 MRQ Gross ProfitJun 30 2026 MRQ Revenue
Tenet Healthcare Corp  97.03 %$ 5,461.000  Millions$ 5,628.000  Millions
Brookdale Senior Living Inc   90.73 %$ 651.935  Millions$ 718.583  Millions
Lifemd Inc   88.82 %$ 41.997  Millions$ 47.281  Millions
Community Health Systems Inc   85.81 %$ 2,424.000  Millions$ 2,825.000  Millions
Mangoceuticals Inc   84.82 %$ 0.058  Millions$ 0.069  Millions
Sbc Medical Group Holdings Incorporated  73.14 %$ 35.977  Millions$ 49.188  Millions
Teladoc Health Inc   68.56 %$ 416.090  Millions$ 606.927  Millions
Hims and Hers Health Inc   63.83 %$ 480.803  Millions$ 753.214  Millions
Airsculpt Technologies Inc   61.38 %$ 26.333  Millions$ 42.900  Millions
Viemed Healthcare Inc   57.68 %$ 45.048  Millions$ 78.097  Millions
Sotera Health Company  55.38 %$ 177.963  Millions$ 321.375  Millions
Cardiff Lexington Corporation  54.75 %$ 1.182  Millions$ 2.160  Millions
Chemed Corporation  32.90 %$ 221.471  Millions$ 673.251  Millions
Aveanna Healthcare Holdings Inc   32.59 %$ 218.525  Millions$ 670.483  Millions
Addus Homecare Corp  32.21 %$ 121.560  Millions$ 377.417  Millions
Concentra Group Holdings Parent Inc   31.70 %$ 192.097  Millions$ 606.030  Millions
Progyny Inc   25.48 %$ 89.301  Millions$ 350.511  Millions
Marpai Inc  23.93 %$ 0.997  Millions$ 4.166  Millions
Pacs Group Inc   22.29 %$ 318.339  Millions$ 1,427.998  Millions
Ensign Group Inc  21.26 %$ 306.244  Millions$ 1,440.481  Millions




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.